Guang Xu

机构：Beijing University of Chinese Medicine, Ezhou Central Hospital, Jiangxi Provincial People's Hospital, People's Hospital of Bishan District · ORCID：0000-0001-9960-6894

发表论文 73 篇 · 总被引 2529 次 · h-index 28

代表论文

• The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors (2023 · Frontiers in Immunology · 被引 166)
• Schisandrin C enhances cGAS-STING pathway activation and inhibits HBV replication (2023 · Journal of Ethnopharmacology · 被引 52)
• Flavonoids derived from licorice suppress LPS-induced acute lung injury in mice by inhibiting the cGAS-STING signaling pathway (2023 · Food and Chemical Toxicology · 被引 41)
• Licorice extract inhibits the cGAS-STING pathway and protects against non-alcoholic steatohepatitis (2023 · Frontiers in Pharmacology · 被引 32)
• Helenine blocks NLRP3 activation by disrupting the NEK7-NLRP3 interaction and ameliorates inflammatory diseases (2023 · Phytomedicine · 被引 31)
• Compound Danshen Dripping Pill effectively alleviates cGAS-STING-triggered diseases by disrupting STING-TBK1 interaction (2024 · Phytomedicine · 被引 27)